Protai
Israel
- Tel Aviv
- 05/01/2022
- Seed
- $8,000,000
Protai has built an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered.
- Industry Biotechnology Research
- Website https://www.protai.bio/
- LinkedIn https://www.linkedin.com/company/protai-bio/about/
Related People
Eran SegerCo Founder
Israel -
Tel Aviv
My passion lays at the intersection of cutting edge technology and innovative biology. Building on over 15 years of experience in various leadership positions in the High-tech & Cyber field together with my knowledge and passion for the computational-bio space, I co-founded Protai a tech driven drug development computational biology startup.
Protai has built an end-to-end AI-based platform that comprehensively maps the course of a disease on the protein level, unmasking deep cellular function to improve the way new drugs are discovered.
Project Eleven | $20,000,000 | (Jan 16, 2026)
CYB3R OPERATIONS | $5,400,000 | (Jan 16, 2026)
Quadric | $30,000,000 | (Jan 16, 2026)
GovDash | $30,000,000 | (Jan 16, 2026)
RouteSense | $2,000,000 | (Jan 16, 2026)
Vista AI | $29,500,000 | (Jan 16, 2026)
depthfirst | $40,000,000 | (Jan 16, 2026)
Slips | $3,500,000 | (Jan 16, 2026)
FOVC | $2,000,000 | (Jan 16, 2026)
VoiceRun | $5,500,000 | (Jan 16, 2026)
Emversity | $30,000,000 | (Jan 16, 2026)
Ammobia | $7,500,000 | (Jan 16, 2026)
Pinch AI | $5,000,000 | (Jan 16, 2026)